Quantcast
Home > Quotes > EDSA

Edesa Biotech, Inc. Common Shares (EDSA) Quote & Summary Data

EDSA 
$6.6
*  
0.10
1.54%
Get EDSA Alerts
*Delayed - data as of Jun. 26, 2019  -  Find a broker to begin trading EDSA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    EDSA Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
44.991
Today's High / Low
$ 6.8035 / $ 6.31
Share Volume
66,451
50 Day Avg. Daily Volume
1,406,704
Previous Close
$ 6.50
52 Week High / Low
$ 13.56 / $ 0.75
Market Cap
47,112,338
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Special Dividend Data

Special Dividend
N/A
Special Dividend Date
Jun. 10, 2019
Special Dividend Payment Date
N/A

Intraday Chart

Shares Traded

Share Volume:
66,451
50 Day Avg. Daily Volume:
1,406,704

Trading Range

The current last sale of $6.60 is 780.00% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 6.8035 $ 13.56
 Low: $ 6.31 $ 0.75

Company Description (as filed with the SEC)

We are a biotechnology company engaged in the aquaculture, research and development, manufacture and commercialization of KLH. KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. Immunotherapies (also known as therapeutic vaccines) are an emerging class of treatments that involve using the body's own immune system to target and treat disease. Today, multiple companies and institutions are developing drugs that combine disease-targeting agents with KLH. These disease-targeting agents do not evoke a robust immune response by themselves and thus require conjugation to a carrier molecule like KLH. The versatility of the KLH molecule and its use in multiple drug development pipelines provide numerous commercial opportunities for us.  ... More ...  

Nasdaq Official Price

Open Price:
$ 6.43
Open Date:
Jun. 26, 2019
Close Price:
$ 6.60
Close Date:
Jun. 26, 2019


Research Brokers before you trade

Want to trade FX?

Analyst Info